NSC 617145

CAS No. 203115-63-3

NSC 617145( NSC617145 )

Catalog No. M13160 CAS No. 203115-63-3

NSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 Get Quote
5MG 63 Get Quote
10MG 87 Get Quote
25MG 158 Get Quote
50MG 228 Get Quote
100MG 357 Get Quote
500MG 842 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NSC 617145
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM.
  • Description
    NSC 617145 is a novel small-molecule, selective inhibitor of WRN helicase with IC50 of 230 nM; shows no significant inhibition on BLM, FANCJ, ChlR1, RecQ, and UvrD; acts synergistically with very low concentrations of mitomycin C to inhibit proliferation in a WRN-dependent manner and induce DSB and chromosomal abnormalities in FA-D2(-/-) cells.
  • In Vitro
    NSC 617145 (0.75-3 μM; 24-72 hours) shows maximal inhibition of proliferation (98%) at the lowest concentration in a WRN-specific manner in HeLa cells.NSC 617145 (0.75 μM; 6 hours) induces WRN binding to chromatin and proteasomal degradation.In FA-D2-/- cells, NSC 617145 (0.125 μM) acts synergistically with very low concentrations of Mitomycin C to inhibit proliferation in a WRN-dependent manner and induce double-strand breaks (DSB) and chromosomal abnormalities. NSC 617145 exposure results in enhanced accumulation of DNA-PKcs pS2056 foci and Rad51 foci in Mitomycin C-treated FA-deficient cells, suggesting that WRN helicase inhibition prevents processing of Rad51-mediated recombination products and activates NHEJ.NSC 617145, induces cell cycle arrest and apoptosis in human T-cell leukemia virus type 1 (HTLV-1)-transformed adult T-cell leukemia cells. Cell Viability Assay Cell Line:HeLa cells.Concentration:0.75 μM, 1 μM, 1.5 μM, 2 μM, 3 μM Incubation Time:24 hours, 48 hours, 72 hours Result:Inhibited cell proliferation in a WRN-specific manner.Western Blot Analysis Cell Line:HeLa cells Concentration:0.75 μM Incubation Time:6 hours Result:Caused WRN to become degraded by a proteasome-mediated pathway.
  • In Vivo
    ——
  • Synonyms
    NSC617145
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA Repair Protein
  • Recptor
    DNA Repair Protein
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    203115-63-3
  • Formula Weight
    400.04
  • Molecular Formula
    C13H10Cl4N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 10 mg/mL (25.00 mM)
  • SMILES
    CC(C)(CN1C(=O)C(=C(C1=O)Cl)Cl)CN2C(=O)C(=C(C2=O)Cl)Cl
  • Chemical Name
    1,1'-(2,2-Dimethyl-1,3-propanediyl)bis[3,4-dichloro-1H-pyrrole-2,5-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Aggarwal M, et al. Cancer Res. 2013 Sep 1;73(17):5497-507. 2. Aggarwal M, et al. Cell Cycle. 2013 Oct 15;12(20):3329-35. 3. Moles R, et al. J Hematol Oncol. 2016 Nov 9;9(1):121.
molnova catalog
related products
  • 6-Hydroxy-DL-DOPA

    6-Hydroxy-DL-DOPA is a small-molecule that disrupts with RAD52 oligomerization, inhibits ssDNA binding by RAD52 with IC50 of 1.1 uM and by RAD52 (1 209) with IC50 of 1.6 uM.

  • TH 5427

    TH 5427 (TH5427) is a potent, small molecule NUDT5 (NUDIX5) inhibitor with IC50 of 29 nM, 690-fold selectivity for NUDT5 over MTH1 (NUDT1) in vitro.

  • MLAF50

    MLAF50 is the first small-molecule inhibitor of the REV1 UBM2-Ubiquitin interaction, directly binds to REV1 UBM2 with Kd of 37 uM in SPR assays.